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ABSTRACT
The solution structure for the 27 kDa flavin binding domain of soluble methane
monooxygenase reductase from Methylococcus capsulatus (Bath) was solved by
NMR spectroscopy. The structure consists of a two domains, an FAD binding
domain with a six-stranded antiparallel P-barrel and one a-helix, and an NADH
binding domain with a five-stranded parallel -sheet surrounded by four a-
helices. The FAD cofactor is bound at the interface between the two domains in a
novel conformation. Near this FAD cofactor, a conserved C-terminal
phenylalanine residue is proposed to act as a conformational gate for electron
transfer. Kinetic studies on a series of mutants confirm that this phenylalanine
controls electron transfer by regulating access of NADH substrate to the bound
flavin cofactor.
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Chapter 1: NMR Structure of the Flavin Domain of Soluble
Methane Monooxygenase Reductase from Methylococcus
capsulatus (Bath)
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Introduction
Methane monooxygenases (MMOs) are multi-component enzyme systems
with the extraordinary capability to oxidize the most inert of hydrocarbons,
converting methane to methanol (1-4). They are expressed in methanotrophic
bacteria, which use methane as their only source of energy and carbon. Since
methanotrophs can oxidize a variety of other hydrocarbons and have been
applied for bioremediation, they are of great chemical, biological as well as
commercial interest (5,6).
The soluble methane monooxygenase (sMMO) frorlMethylococcus capsulatus
(Bath) consists of four components, a 251 kDa hydroxylase MMOH, a 15.9 kDa
coupling protein MMOB, a 38.7 kDa reductase MMOR and a 12 kDa protein of as
yet unidentified function, MMOD (7-9). A full understanding of the mode of
action of the enzyme requires the knowledge of the three-dimensional structures
of its proteins. Investigations of the sMMO components from M. capsulatus (Bath)
and other methanotrophs thus far have supplied X-ray crystal structures of
MMOH (10-14) and NMR solution structures of MMOB (15,16) and the MMOR
ferredoxin domain, MMOR-Fd, comprising 98 amino acids (17).
Because of the fairly large size of MMOR and the presence of a paramagnetic
[2Fe-2S] cofactor, solving the NMR structure of the complete protein is
challenging. We therefore decided to pursue this task with a three-step strategy.
First, the structure of the reduced form of the smaller, paramagnetic MMOR-Fd
was determined (17). In the present report we describe the solution structure of
the reduced form of the second, 250 amino acid domain, MMOR-FAD. We chose
to investigate the structure of the fully reduced protein because of its greater
stability and the better comparability with the MMOR-Fd domain, which was
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solved previously in the reduced state. The entire MMOR structure will then be
solved based on these two individual building blocks. Crystal structures of
similar proteins, including phthalate dioxygenase reductase (18) and benzoate-
1,2-dioxygenase reductase (19) have already been solved, providing good
comparisons for an NMR structure. Ultimately, knowledge of this reductase
structure, together with the three-dimensional structure of MMOH, will enable
us to interrogate long-range electron transfer reactions within and between
soluble methane monooxygenase proteins.
Materials and Methods
Expression of MMOR-FAD. An expression system for MMOR-FAD, the flavin
domain of methane monooxygenase reductase, capable of growing on M9
minimal medium with high yields was produced by transforming the plasmid
pFAD21 into competent Escherichia coli BL21(DE3) cells. The plasmid was
constructed by cutting the gene coding for MMOR-FAD out of pRED-FAD (20)
and inserting it into the pET21(+) vector system (Novagen, Inc.), substituting a
T7 promoter for the tac promoter present in pRED-FAD. The cells were grown in
M9 minimal medium at 37 °C with constant shaking at 200 rpm. A concentration
of 100 mg L-1 ampicillin was used for selection. When the OD60 value of the cell
suspension reached 0.6 (or 0.4 for D2 0O-based medium), expression was induced
by adding IPTG to a final concentration of 0.1 mM. Cells were harvested after 12-
15 hours, and the protein was purified as described previously (20). The
concentration of MMOR-FAD was determined by using an extinction coefficient
of 458 = 11,300 M- l cm-l (20). Because no FAD was added to any of the media, all
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of the cofactor incorporated into the protein had to be synthesized by the E. coli
bacteria. As a consequence, the FAD moiety always showed the same isotopic
labeling pattern as the corresponding protein.
15 N-Labeling of the protein was achieved by introducing 1 g L-1 of 15NH4C1 in
the medium. For uniform 3C-labeled protein, 2 g L-1 of 3C glucose was used.
Biosynthetic fractional 3C labeling was performed with 10% 3C glucose. Two
samples of triple-labeled protein with different levels of deuteration were
obtained by using 5NH4C1, 3C glucose and 70% and 99.9% D20, respectively.
Perdeuterated MMOR-FAD samples with terminally 3C,1H methyl-labeled Ile,
Leu and Val residues were obtained by adding [3- 3C]-a-ketobutyrate and [3,3'-
13 C]-a-ketoisovalerate to the medium, as described previously (21,22). In
addition, 150 mg L1 of natural abundance Phe, Tyr and Trp were added at the
same time as the ILV-precursors to obtain 1H labeling of aromatic side chains.
Perdeuterated MMOR-FAD samples with protonated Tyr and Trp or Phe side
chains were prepared by adding 15N labeled Phe or 15N labeled Tyr and
unlabeled Trp to media containing 15NH4C1, 1,2,3,4,5,6,6-2H-D-glucose and 99.9%
D20. For selective 15N amide labeling of Val, Phe, Tyr and Leu residues, the
plasmid pRED-FAD was transformed into competent E. coli DL39 cells, which
are auxotrophs for Asp, Ile, Leu, Phe, Tyr and Val. The resulting cells were
grown in M9 minimal medium supplemented with 100 mg L-l of each of the six
amino acids, one of them with a SN-labeled amide group. Reverse selective
labeling of Arg residues was achieved by growing BL21(DE3)/pRED-FAD cells
in M9 minimal medium supplemented with 1 g L-l of 15NH4C1 and 100 mg L-l of
natural abundance Arg. All isotopically labeled minimal media components and
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amino acids, with the exception of the ILV precursors, were purchased from
Cambridge Isotope Laboratories.
NMR Experiments. NMR experiments were performed with reduced 0.6 - 1.0
mM MMOR-FAD in 50 mM Na phosphate buffer, final pH of 6.7 after addition of
Na2S204, with 1 mM DTT, 0.1% NaN 3 and 2 mM Pefabloc (Roche Diagnostics
GmbH, Germany). A final amount of 30 mM Na2S204 and 3 equiv of NADH had
to be added to keep the protein reduced. NMR tubes were filled under a nitrogen
atmosphere and flame sealed.
Spectra were acquired at 750 MHz (Varian Unity Inova), 600 MHz (Bruker
DRX) or 500 MHz (Bruker DRX equipped with a cryoprobe, or Varian Inova) at
25 °C unless stated otherwise. Backbone resonance assignments were obtained
by using three-dimensional TROSY heteronuclear experiments (HNCA,
HN(CO)CA, HN(CA)CB, HN(COCA)CB, HNCO, HN(CA)CO) and selective
labeling techniques (23). Side chain assignments were obtained by using H(C-
CO)NH-TOCSY, (H)C(CO)NH-TOCSY, '5N TOCSY-HSQC, 15N NOESY-HSQC,
and 13C NOESY-HSQC experiments (23). Stereospecific assignments of the
methyl groups of 13 Leu and 10 Val residues were obtained with biosynthetic
fractional 3C labeling (24). Distance constraints were collected from 15N NOESY-
HSQC (100 ms mixing time at 25 °C and 60 ms mixing time at 35 °C), 13C NOESY-
HSQC (100 ms mixing time, fully 3C-labeled protein), 13C HMQC-NOESY (80 ms
mixing time, ILV-methyl labeled protein with additionally 'H-labeled (a) Tyr and
Trp and (b) Phe residues), and homonuclear proton NOESY experiments (60 ms
mixing time). Additional long-range distance constraints were gathered from 15N
labeled, deuterated protein with protonated (a) Tyr and Trp or (b) Phe (180 ms,
25 C) by 15N NOESY-HSQC. Spectra were processed with FELIX (Molecular
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Simulations Inc., San Diego) or PROSA (25) and analyzed with XEASY (26) on
Silicon Graphics work stations. The dihedral angle constraints for j and V used
in the calculations were obtained with the computer program TALOS (27).
Structure Calculations. NOESY crosspeaks were integrated by using the
integration routine in the program DYANA (28). Interatomic upper-distance
limits were calculated with the program CALIBA (29) based on NOESY
crosspeak intensities for shorter mixing time experiments, or by collecting peak
volumes into several bins and converting to distance by a factor of r6 for
experiments with long mixing times. Initial structure calculations were
performed on Silicon Graphics workstations with the computer program
DYANA (28) using simulated annealing by molecular dynamics in dihedral
angle space. At all stages of the calculations, hydrogen bond constraints were
introduced for residues determined to be in an a helix or a P strand. For each
hydrogen bond two constraints were included into the calculations,
dN,...o = 1.8 - 2.4 A and dN...o = 2.8 - 3.4 A. Methyl-methyl and methyl-aromatic
constraints were added in later stage simulated annealing calculations performed
in X-PLOR (30).
The FAD cofactor was incorporated into calculations by creating topology and
parameter files in the program XPL02D (31) from pdb coordinates of FAD in the
crystal structure of the NADPH:ferredoxin reductase (FdR) from Azotobacter
vinelandii (PDB code 1A8P) (32). Hydrogen atoms were added to FAD to result in
the species FADH2, which was optimized in InsightII (Accelrys, Inc.) prior to
conversion in XPL02D. The files were appended to earlier protein simulated
annealing calculations for final structure calculation, and structures were viewed
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and statistics calculated using VMD (33). Protein figures were created with the
program MOLMOL (34).
Results
NMR Experiments. Backbone heavy atom and CO resonances were assigned by
using eight TROSY triple resonance experiments (HNCA/HN(CO)CA for 70%
and 99% protein deuteration levels, HN(CA)CB/HN(COCA)CB and
HNCO/ HN(CA)CO) and 15N selective labeling of valine, phenylalanine, tyrosine
and leucine, and reverse labeling of arginine residues as described previously
(23,35). Resonances of 37 residues with extremely slowly exchanging amide
protons were not detected in the triple resonance spectra of MMOR-FAD at the
99% deuteration level but could be assigned with an additional
HNCA/HN(CO)CA pair when using protein with approximately 70%
deuteration. These slow-exchanging protons were primarily found in the FAD-
binding domain, including amide protons for amino acids 14-17, 27-32, 50-52, 54,
63-65, 69, 71, 73-79, 83, 85-88, 91-92 and 101-103. Residue 191 was the only amino
acid of this type in the NADH-binding domain. Secondary structure elements
were identified based on 3C chemical shift indices (36), dihedral angle
constraints obtained from the program TALOS (27), and an analysis of NOE
crosspeak patterns in the '5N NOESY-HSQC and 3C NOESY-HSQC spectra
typical for c helices and I strands.
Significant improvement of peak resolution in the aliphatic region of thd3C,
1H spectra was observed for ILV-F and ILV-YW labeled proteins, as shown in
Figure 1-1. This gain in resolution is obtained not only by limiting the total
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number of 3C labeled groups, but also by providing spectra in which these
protonated methyl groups are embedded in an otherwise perdeuterated
background. A total of 247 methyl-methyl and methyl-aromatic constraints were
collected from these experiments, greatly improving previously unstructured
hydrophobic regions with few constraints. Additional long mixing time
experiments on perdeuterated, 15N labeled protein with protonated Phe or Trp
and Tyr side chains allowed assignment of aromatic protons and provided
further long-range distance information. Several constraints between backbone
amide protons and aromatic side chains to the N3 amide proton of the
isoalloxazine moiety were also obtained to constrain the cofactor.
Solution Structure. For structure calculation, a total of 3653 constraints were
used. Included are 1559 intra-residue constraints, 671 sequential, 239 medium-
range and 434 long-range NOE constraints, along with 247 methyl-methyl and
methyl-aromatic NOE constraints from the spectra using ILV-labeled protein, 172
hydrogen-bond constraints and 331 dihedral angle constraints. Of these
constraints, 21 NOE, 90 dihedral and two hydrogen-bond restraints were used to
constrain the FAD cofactor within the protein structure. The core region of the
protein, residues 10-250, has an average backbone rmsd of 0.98 A for the set of 10
lowest energy structures. Average backbone rmsd values for secondary
structures within individual domains, residues 10 to 111 for the FAD binding
domain and 113 to 245 for the NADH binding domain, were 0.89 and 0.84,
respectively. Structural statistics are summarized in Table 1. All calculated
structures for MMOR-FAD converged, with the lowest energy structures
containing no distance constraint violations greater than 0.5 A or dihedral angle
constraint violations greater than 5 degrees.
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The NMR structure in Figure 1-2 reveals that MMOR-FAD consists of two
domains, one containing the FAD cofactor and the other binding NADH. This
structural feature is characteristic of proteins in the flavoprotein electron
transferase family such as MMOR, phthalate dioxygenase reductase (PDR) (18),
benzoate 1,2-dioxygenase reductase (BenC) (19) or NADPH:ferredoxin reductase
(32). Figure 1-3a shows the sequence homology of MMOR-FAD to the flavin and
NAD(P)H binding domains of these proteins. The FAD-binding domain of
MMOR-FAD folds into a cylindrical six-stranded antiparallel Pf sheet and
contains one a helix covering one opening of the cylinder. Many of the residues
with slow-exchanging amide protons mentioned above are located within this 3
sheet, suggesting a rather rigid structure. The unstructured residues 2-10 are part
of the linker between the Fd and FAD binding domains in the full-length protein.
Residues 11-23 comprise strands Ffla and Ff3lb, which are broken by a loop
region of residues 17-19 and are the first strand of the 3-barrel. A tight loop back
to strand Ff32 (26-33) forms the next part of the sheet and is followed by a long,
unstructured loop of residues 34 to 49. A short strand Ffi3 (50-53), loop and FfP4
(62-65) continue the cylinder sheet, followed by another, shorter unstructured
loop of residues 66-75, parallel to the longer unstructured loop (34-49). Strand
FP5 (76-80) leads into a loop of residues 81-88, followed by helix Fal (89-94)
along one end of the P-barrel structure, which leads into Ff36 (101-105), also part
of the f3 sheet. Residues 106 to 120 form a coil linking the two domains. There is a
cleft between strands Ff34 and Ff35, between which the isoalloxazine moiety and
ribotyl chain of FAD binds. Direct evidence for flavin ring binding is seen in
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NMR spectra as discussed further below, and ribotyl chain binding is expected
based on sequence homology to other flavin-binding proteins.
The NADH binding domain contains alternating beta strands and alpha
helices forming a five-stranded parallel [3 sheet with two a helices positioned on
each side of the sheet, thus resulting in a classical nucleotide binding fold.
Residues 121 to 126 make up the central strand N(31 of this domain, followed by
helix Nal comprising residues 130-143. After this helix, residues 144-148 loop
leading into strand NO2 (149-154), next to NP1, followed by a long loop of
residues 155-163 into helix Na2 (164-173), then a short loop to strand NO3 (178-
181) at the edge of the parallel [3 sheet. Another long loop leads to helix Na3 with
residues 199 to 207, followed by a loop to residues 213-217 in strand N[34 packed
on the opposite side of strand N[1. A short loop leads into the long helix Na4,
with residues 220-233, which winds around in a long loop to strand N135 (237-
244). This final 3 strand sits next to N[34, finishing the 13 sheet with a strand order
of N[3-N[2-N[31-N[34-N[35. The C-terminal tail loops back into the protein and
rests between helices Na2 and Na3 and the [3 sheet.
FAD Cofactor Interactions. To constrain the FAD cofactor, a total of 21 FAD-
protein and FAD-FAD NOEs were used, as well as one hydrogen bond, as
shown in Figure 1-4. Both the C7 and C8 methyl groups on the flavin ring were
observable in '3C NOESY-HSQC spectra, and both the adenine-N6 amine and
isoalloxazine-N3 amide protons were evident in 15N NOESY-HSQC spectra. The
15N chemical shifts of 147 ppm for N3 on the isoalloxazine ring and 79 ppm for
AN6 on the adenine ring agree well with previously reported values of 145-154
ppm, for reduced flavins bound to proteins (37-39), and of 82-83 ppm, for free
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l5N-labeled adenine, respectively (40). We were unable to definitively assign
additional peaks to the FAD cofactor, due to the resolution of collected spectra
and peak crowding in expected regions for chemical shifts. Assignment for
remaining nitrogen atoms in FAD, as well as for ribityl and ribotyl carbon and
hydrogen atoms was ambiguous. The crosspeaks for FAD HN3 are given in
Figure 1-5, along with corresponding backbone amide peaks for residues Ser65,
Leu79, Arg81 and Leu246, showing the presence of several short contacts
between the latter residues and the isoalloxazine group. The unusual upfield
shift of the Leu246 amide proton suggests that it is stacking on top of the
isoalloxazine ring. The amide peak for conserved Phe88 is shifted downfield to
12.04 ppm in the 1H dimension, ~2 ppm from other amide peaks in the spectrum.
Furthermore, the magnitude of the peak in '5N labeled, perdeuterated protein
exchanged into water is much smaller than average amide peaks, suggesting
slow exchange. Together, these results provide evidence for a stable hydrogen
bond involving the Phe88 amide proton. Since the 15N NOESY-HSQC spectra did
not reveal the identity of the corresponding hydrogen bond acceptor, and
because in early structure calculations this amide proton was pointing towards
the AMP phosphate of the FAD cofactor, two hydrogen bond constraints were
added during later stages of the calculation.
FAD is located at the interface between the domains (Figure 1-6), and
converges in all structures with an rmsd value of 0.77 A. The isoalloxazine
moiety binds at the cleft between F14 and Ff5 in the FAD domain, with the C7M
and C8M methyl groups protruding towards the linker between the two
domains. The ribotyl chain extends along the cleft in the N-terminal domain 3
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sheet, and the AMP phosphate group binds along the loop between Ft5 and Fal,
its negative charge being compensated by an arginine side chain (Arg87). Amino
acids Thr128 / Gly129 and the C-terminal tail residues Phe245 and the amide
proton of Leu246 lie near the re-face of the flavin ring. Experimental proof for
this alignment can be found for example in the shielding of the Leu246 amide
proton by the ring current effect of the flavin ring, resulting in an anomalous
upfield shift (Figure 1-5). The N6 amine group of adenine is located along the
loops between Nj32 and Na2 (residues 156-160) and NP3 and Na3 (residues 187-
189), creating an extended conformation of FAD with adenine binding along the
edge of the domain interface away from the chain linking the domains. Figure 1-
7 shows the FAD cofactor binding site and summarizes interactions between
FAD and the protein.
Discussion
MMOR-FAD Structure. MMOR has high sequence homology to other
members of the flavoprotein electron transferase family. The FAD/NADH
binding domain of MMOR is structurally homologous to several other members
of this class of proteins, most notably benzoate-1,2 dioxygenase reductase from
Acinetobacter sp. strain ADP1 (19). Since BenC has an identical arrangement of
ferredoxin, FAD and NADH binding domains, MMOR can be expected to have a
similar structure. The structures for the FAD and NADH binding domains in
both proteins are similar, with an rmsd value of 3.8 A for superimposed
structures. The major difference between these proteins occurs at the C-
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terminus, where the MMOR tail folds back into the NADH binding domain,
whereas BenC has a tail extending to the surface of the protein.
The FAD binding domain in MMOR is composed of an antiparalle barrel
with an a helix at one opening of the barrel. This domain is structurally
homologous to other FAD binding domains. Residues binding the FAD cofactor
are strictly, conserved within the reductase proteins of soluble MMO of
methanotrophs, as shown in Figure 1-3b. The FAD itself is in an extended
conformation so that the adenine moiety is distal from the isoalloxazine ring.
This arrangement of the cofactor is unlike any conformation previously
determined in the X-ray crystal structure analyses of homologous proteins
(Figure 1-8d). Those structural studies resulted either in a bent conformation
having the AMP moiety folding back towards the flavin ring or in an "extended"
conformation where adenine is oriented away from it. In the bent conformation,
the adenine group is held in place by hydrogen bonds involving its N6 and N7
nitrogen atoms and 03' of the ribityl moiety (FdR, Figure 1-8c; BenC, Figure 1-8a)
(18,19,32) with or without additional stabilization by stacking of an aromatic
residue in the C-terminal region of the protein (Phe255 in FdR, Trp248 in
flavodoxin reductase (FlxR) (41), no stacking in BenC). In the previously
established "extended" conformation, no hydrogen bonding within the cofactor
was observed. Instead, stacking on a tyrosine side chain within an extended loop
in the N-terminal domain preceding Fal was used for stabilization (Tyrl20 in
spinach ferredoxin-NADP+ reductase (FNR), Figure 1-8b; TyrlO04 in Anabaena
FNR) (42-44). In the conformation found in MMOR-FAD, neither stacking on an
aromatic side chain nor intra-residue hydrogen bonding is observed for the
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adenine moiety. Because of the presence of only a short loop between F36 and
Fal, this behavior was predicted previously (41). The negative charge of the FAD
phosphate groups is compensated by arginine side chains Arg62 and Arg87
(Figure 1-6), the first of which is strictly conserved within the sMMO family
(Figure 1-3), and a hydrogen bond from the Phe88 amide group at the N-
terminus of Fal. Similar charge neutralization occurs in several other proteins of
the flavodoxin reductase family (32,41,43). The isoalloxazine ring is in a very
similar environment in all of the structures mentioned above, including MMOR-
FAD. Nearly all structures display stacking of an aromatic residue from the C-
terminal region of the protein (Phe245 in MMOR-FAD, none in FdR, Phe335 in
BenC, Tyr247 in FlxR, Tyr314 in spinach FNR, Tyr303 in Anabaena FNR) on the re-
face of the flavin ring, and all of them feature a non-perpendicular stacking
interaction with a conserved tyrosine from the N-terminal domain on the si-face
(Tyr64 in MMOR-FAD, Tyr53 in FdR, Tyr158 in BenC, Tyr52 in FlxR, Tyr95 in
spinach FNR, Tyr79 in Anabaena FNR). The conserved tyrosine interaction with
the si-face of the flavin ring has been proposed to be responsible for the correct
positioning of the cofactor (45).
The loops at the end of the I barrel opposite to Fal, residues 34-49 and 65-75,
are less structured than the rest of the domain. In the crystal structures of PDR
and BenC (19), the ferredoxin domain, which is missing in MMOR-FAD, is
located in this region of the protein, suggesting that the disorder found here
might arise from the absence of the ferredoxin domain in MMOR-FAD. The full-
length structure of MMOR should resolve or further explain this discrepancy as
well as that of the unusual FAD conformation. Additionally, the unstructured N-
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terminal chain should have a defined structure as a linker region between the
ferredoxin and FAD binding domains.
NADH binding to MMOR-FAD could not be observed by NMR spectroscopy.
No detectable signal of or crosspeaks to bound NADH, present in threefold
excess in the solution, could be assigned in the NMR spectra. This result is not
surprising considering in its reduced form the protein has no requirement to
bind additional NADH. Based on sequence homology to other FNR proteins
crystallized with NAD(P)H analogues, NADH is expected to bind at the carboxy-
terminal edge of N131 and Nf34 of the parallel i sheet (19,43). The conserved
sequence GxGxxP (127-132), comprising the loop between NO1 and the N-
terminus of Nal, probably binds the diphosphate bridge in NADH (46). The
adenine moiety is expected to be positioned between the N-terminus of Nc4 and
the loop preceding Na3 (18,19,43), facing away from the flavin-binding domain.
Structural Implications for Electron Transfer. Ferredoxin-NADP reductases are a
remarkable family of proteins that can transfer electrons from ferredoxin to
NAD(P)+, or in the reverse direction through a bound flavin cofactor. The
direction of electron transfer is determined by the redox potentials of the
cofactors, which are modulated by the surrounding protein (47). Redox
potentials of FAD in MMOR are pH dependent (20,48), meaning that charged
residues within MMOR modulate redox potential.
Phe245 (F342 in MMOR) is a conserved aromatic residue proposed in other
proteins to act as a conformational gate regulating access of the nicotinamide
moiety of NADH to the isoalloxazine ring (19). In the solution structure of the
reduced protein, Phe245 is approximately 3.0 A away from the re-face of FAD.
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Direct evidence for these interactions is observed in long mixing time (180 ms)
1H, 5N NOESY spectra of perdeuterated, 5N labeled protein with protonated
phenylalanine side chains. For the reduced form of MMOR, it is expected that
this gate should block additional reduction by preventing binding of NADH, as
well as stopping back electron transfer to oxidized NAD* by inducing its
dissociation. Stopped flow experiments on both MMOR (48) and MMOR-FAD
(20) give rate constants of 350 sl for a step after NADH binding prior to
formation of a charge transfer complex between NADH and FAD. Based on our
structure and the suggested role of Phe245 as a conformational gate, we propose
that the gating movement of Phe245 and the concomitant displacement of the
protein backbone are responsible for this observed rate constant for conversion
of the initial Michaelis complex to the observed CT1 intermediate. In full length
MMOR, electron transfer from the FAD cofactor to the [2Fe-2S] cluster occurs
with a rate constant of 90 s, while NAD* simultaneously dissociates from
MMOR (48). Kinetics data from MMOR-FAD alone measure this rate constant for
dissociation to be 89 s without electron transfer (20). Thus additional
conformational changes in the protein as a result of NAD* dissociation appear to
be responsible for regulating electron transfer.
Conclusions We have solved the solution structure of the reduced FAD and NADH
binding domains of MMOR by NMR spectroscopy. The results provide important
structural information for the FAD and NADH binding domains in a reductase
component of soluble MMO. Based on sequence homology, other sMMO reductases are
expected to display similar protein folds. The structure of these domains is closely related
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to those available for other members of the FNR family, whereas the FAD cofactor is
found in an unprecedented extended conformation. Information gathered from these
results, together with the previously determined structure of MMOR-Fd (17), will
facilitate solution of the full-length MMOR structure and ultimately allow a greater
understanding of the mechanism of electron transfer within sMMO.
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Table 1. Statistics for the MMOR-FAD Solution Structure
NOE distance constraints
Intra-residue
Sequential ( i-j I =1)
Medium range (I i-j I 4)
i, i+2
i, i+3
i, i+4
Long Range (I i-j I 5)
Methyl constraints
H bond constraints
Dihedral angle constraints a
Average ensemble RMSD:
FAD domain (10-111)
NADH domain (113-250)
Backbone (10-250)
3150
1559
671
239
92
100
47
434
247
172
331
0.89 A
0.84 A
0.98 A
Procheck Analysis (percent)
Most favored
Additional allowed
Generously allowed
Disallowed region
90.2", 67.2c
8.3, 21.1 c
1.0, 8.7c
0.4b, 3.0c
a Dihedral angle constraints as obtained with TALOS
DYANA (28) based on NOE constraints.
h Regular secondary structure
c Structured Region (residues 10-251)
(27) or generated using
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FIGURE 1-1. The aliphatic region of 13C, 1H HSQC spectra of MMOR-FAD for (A)
uniformly 3C labeled MMOR-FAD (spectrum recorded on 500 MHz Bruker
NMR spectrometer with cryoprobe for 1 mM protein sample) and (B) 13C
terminal methyl (ILV) labeled MMOR-FAD (0.6 mM protein sample, spectrum
recorded on 600 MHz Bruker NMR spectrometer).
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FIGURE 1-2. Solution structure of the FAD- and NADH- binding domains of
MMOR. (A) The backbone atoms (N,Ca,C) of the 10 lowest energy NMR-derived
structures are displayed in stereo view (residues 10-251). Secondary structural
elements are shown colored in blue ( sheet) and red (a helix). This figure was
created by superimposing backbone atoms for residues 10-250 using MOLMOL
(34). (B) Ribbon diagram and nomenclature of FAD- and NADH-domains, with
bound FAD cofactor shown in blue at the interface between the two domains.
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FIGURE 1-3. Sequence alignments of (A) FAD and NAD(P)H binding domain
secondary structure of MMOR with benzoate-1,2-dioxygenase reductase (BenC,
PDB code 1KRH) (19), phthalate dioxygenase reductase (PDR, PDB code 2PIA)
(18), and NADPH:ferredoxin reductase (FdR, PDB code 1A8P) (32). Secondary
structural elements are highlighted in red (a helices) or cyan ( sheets). (B)
Sequence alignments of the FAD and NADH binding domains of the reductases
in soluble MMO from methanotrophs M. capsulatus (Bath) (8,49), Methylomonas
sp. strains KSWIII and KSPIII (50), Methylosinus trichosporium OB3b (51,52),
Methylocystis sp. strain M (53), and Methylocystis sp. strain Wi 14 (54). Identical
residues are highlighted in dark green, whereas similar residues are in light
green. Residues marked with arrows are discussed in the text as being involved
in FAD binding. Figures were made using BioEdit (55).
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FIGURE 1-4. Intermolecular NOEs and hydrogen bonds between the protein and
FAD cofactor. FAD is shown in black, with atom names listed, and blue arrows
indicate intermolecular NOEs. The hydrogen bond between Phe88 and the
phosphate oxygen AO1 is shown as a cyan dashed line.
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FIGURE 1-5. Selected strips from the 180 ms mixing time 15N NOESY-HSQC
spectrum with protonated Y and W residues in 15N, 2H labeled protein. FAD252
has a peak for HN3 in the first strip, with crosspeaks to H'2 and HO3 of Tyr64, HN
of Ser65, HN of Leu79, HN of Arg8l and HN of Leu246. The corresponding
strips show the amide peaks and their crosspeaks to FAD252. These interactions
are direct evidence for FAD binding in MMOR-FAD.
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FIGURE 1-6. Electrostatic surface plot of the MMOR-FAD protein core (residues
11-251), revealing that the FAD cofactor is located in a cleft between the two
domains. Red and blue represent negative and positive partial charges,
respectively. The FAD prosthetic group is shown in green (dark green:
riboflavin, green: phosphate groups, light green: adenosine). The positive charge
provided by arginine side chains of the FAD-binding domain stabilizing the
phosphate groups is clearly discernible. This figure was generated with an
algorithm (56) implemented in MolMol using relative dielectric constants of 3
and 80 for the protein and surrounding water, respectively. A box extending 10
away from the protein in each direction was used when calculating the potential.
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FIGURE 1-7. Experimentally observed contacts between FAD cofactor and protein.
FAD is in blue, the residues Phe245, Tyr64 and Phe88 as discussed in the text are
shown in orange, red, and black, respectively. The hydrogen bond pointing from
the Phe88 amide proton to the AMP phosphate group is also shown. Amino
acids with observed contacts to the adenine-N6 group are in dark green, those
with contacts to the flavin methyl groups are in green. N-H bonds are displayed
in yellow for residues with short contacts to the isoalloxazine N3 amide proton.
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FIGURE 1-8. Comparison of the conformation of the FAD cofactor in different
protein structures. A: BenC, B: spinach FNR, C: FdR, D: MMOR-FAD.
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Chapter 2: Investigation of the Role of Phe 342 as a Conformational
Gate for Electron Transfer in MMOR
52
Introduction
Methanotrophic bacteria utilize methane as a primary carbon and energy
source, a remarkable feat given that the C-H bond in methane is one of the most
stable found in nature with an energy of 104 kcal/mol. The first step in the
pathway of carbon uptake is the conversion of methane to methanol, catalyzed
by the multi-enzyme methane monooxygenase (MMO) system and shown in
equation 1 (1-4).
CH4 + NADH + H +0 2 - CH30H + NAD+ + H20 (1)
The MMO system is found in both particulate and soluble forms, the former
being a copper-containing oxygenase whereas the latter is expressed under low
copper conditions. Soluble MMO from Methylococcus capsulatus (Bath) consists of
four enzymes: a 251 kDa a21,2y2 hydroxylase component containing a diiron site
in each a subunit responsible for 02 activation and hydroxylation of methane, a
15.9 kDa regulatory protein MMOB, the 38.7 kDa reductase (MMOR) which
transfers electrons from NADH into the diiron site in the hydroxylase, and a
fourth 12 kDa component (MMOD) of undetermined function (5-7). Structures
for MMOH in various redox states were solved by X-ray crystallography (8-12),
and NMR spectroscopy was used to solve the structures of MMOB (13,14), and
both the ferredoxin (15) and flavin-binding (16) domains of MMOR in the
reduced state.
The reductase component is structurally homologous to other dioxygenase
reductase proteins, most notably benzoate-1,2-dioxygenase reductase, or BenC
(17), and phthalate dioxygenase reductase, PDR (18), both structures having been
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solved previously by X-ray crystallography. These proteins are all members of
the ferredoxin-NADP* reductase (FNR) subfamily, one subset of the flavodoxin
family. This subfamily is named for the ferredoxin-NADP* reductases, part of the
photosynthetic pathway. These proteins utilize a conserved flavin-binding
domain with a six-stranded antiparallel beta barrel structure having a single
alpha helix at one end, together with a conserved pyridine nucleotide-binding
domain containing a five-stranded parallel beta sheet surrounded by 4-9 alpha
helices. FAD or FMN is bound along the interface between the two domains.
Ferredoxin-NADP* reductases transfer electrons from separate ferredoxin
molecules to reduce NADP* to NADPH via the flavin cofactor. The linked
monooxygenase and dioxygenase reductases MMOR, PDR, and BenC have the
ferredoxin domain attached to the N- or C- terminus of the FNR protein and
transfer electrons in the opposite direction, using NADH to reduce the
ferredoxin domain. Figure 2-1 diagrams the various links between domains of
these proteins. Modulation of redox potentials of bound cofactors by
surrounding protein enables this basic scaffold to transfer electrons in both
directions (19).
One feature of the FNR subfamily is a conserved C-terminal aromatic residue
located spatially near the re-face of the isoalloxazine ring. This residue is a
conserved tyrosine for ferredoxin-NADP+ reductases, whereas phenylalanine is
in this position for proteins like MMOR and BenC. This tyrosine residue has been
proposed to play a catalytic role for FNR by acting as a conformational gate, as
well as modulating FAD redox potentials and formation of the ternary complex
with ferredoxin (20). A similar conformational role for the C-terminal
phenylalanine in MMOR, PDR, BenC and in nitric oxide synthases has been
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proposed based on crystal and solution structures of these proteins (16-18,21).
Figure 2-2 shows Phe 245 in the reduced MMOR-FAD domain with its side chain
parallel to the flavin ring in the purported nicotinamide binding site for NADH.
In this chapter, mutants of C-terminal phenylalanine residue 342 in the full-
length reductase or Phe 245 in the MMOR-FAD flavin domain were created to
investigate the role of this amino acid.
Materials and Methods
Site-Directed Mutagenesis. The QuikChange II kit (Stratagene) was used for
mutagenesis. Mutants of the MMOR-FAD domain protein were constructed
using a pET21(+) plasmid containing the recombinant gene for MMOR-FAD,
pFAD21. Full-length MMOR mutants were created with recombinant plasmid
pRED24, a pET24(+) construct containing the mmoC gene. The 31-mer primers
were purchased from Invitrogen and were created using a Stratagene toolkit
program to optimize length and melting temperature of primers for use in the
QuikChange protocol. For the F245Y and F342Y mutants, primer sequences
5'GGTCTTCTTCGAAAAATACCTGCCGTCCGGG 3' and 5'-CCCGGACGGC
AGGTATTTTTCGAAGAAGACC-3', with mutation sites underlined, were used.
Corresponding primers for F245A / F342A and F245L / F342L contained mutations
GCC/GGC or CTC/GAG in the underlined regions of the previous sense and
antisense primers, respectively. Mutants were constructed by using 15-20 12 or
15 min PCR cycles with PfuTurbo DNA polymerase. The resulting plasmid
mixture was treated with restriction enzyme DpnI to remove nonmutated
template DNA and transformed into supercompetent XL-1 Blue cells. Resulting
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colonies were grown in 5 mL cultures overnight, and plasmids were isolated
from these cells using a Qiaprep spin miniprep kit (Qiagen). The plasmids
obtained were sequenced by the MIT Biopolymers facility to verify the presence
of the appropriate gene mutation, and BL21(DE3) cells were transformed with
mutant-containing plasmids.
Expression and Purification. MMOR-FAD domain protein mutants were grown
in 1L cultures of LB media with 100 mM ampicillin added. Cells were grown to
an OD600 of 0.6, then induced with 1 mM IPTG and induced for 3 h. Cells were
centrifuged and lysed by sonication. Crude protein was purified as described
previously (22). Full-length MMOR mutants were grown in M9 minimal media
with 30 mg/L kanamycin to OD600 of 0.6, followed by a 6 h induction period with
0.1 mM IPTG. Cells were centrifuged to harvest and lysed by sonication in the
presence of 500 FtM MgC12, 10 FL DNase I, 12.5 mg Pefabloc protease inhibitor
and approximately 100 mg PMSF in 20 mM Tris buffer, pH 7.2 with 50 mM NaCl
and 8 mM sodium thioglycolate. MMOR mutants were purified as described
previously (23). Purity of isolated mutant proteins was verified by SDS-PAGE
with 4-20% Tris-HCl gradient gels (BioRad). Purified protein was desalted and
exchanged into 25 mM MOPS, pH 7.0 with 1 mM DTT for storage at -80 °C.
Characterization of Mutants. UV-visible spectra for mutants were recorded on
a HP 8453 spectrophotometer. Spectra were recorded for the oxidized protein in
25 mM MOPS buffer, pH 7.0. Flavin content was determined by comparing the
ratio of absorbances at 270 and 458 nm, with a value of ~6.7 corresponding to 1
FAD cofactor per protein.
Iron content for the full-length proteins was determined by assaying reduced
Fe2 ' with ferrozine. Iron was reduced to Fe2 ' by addition of ascorbic acid, and
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protein was precipitated by using 0.7 M trichloroacetic acid. To the resulting
supernatant was added ferrozine and the reaction was taken to completion,
approximately 20 min. The concentration of the colored complex was measured
at 562 nm on a UV-vis spectrophotometer. Protein samples were compared to a
standard curve to determine the iron content of the mutant reductase forms.
Stopped-Flow Experiments. All experiments were performed on a Hi-Tech
model SF-61 DX2 instrument with a photomultiplier and tungsten lamp for
single wavelength mode or diode array detection with a 75 W xenon arc lamp.
Syringes and the flow line were made anaerobic by filling with 25 mM MOPS
buffer, pH 7.0 containing approximately 5 mM sodium dithionite for
approximately 30-45 min, followed by a flush of the system with anaerobic 25
mM MOPS buffer, pH 7.0. All buffers and NADH solutions were made anaerobic
by bubbling nitrogen through the solution for at least 30 min. Protein samples
were made anaerobic by running 12-15 cycles of vacuum/nitrogen gas exchange.
Samples were run at 4.0 C, and all data were recorded with a logarithmic time
base. Data from single wavelength absorbance experiments were fit using the
program KinetAsyst v. 2.0 (Hi-Tech, Ltd).
Results
Characterization of MMOR-FAD mutants. All mutants of MMOR-FAD were
expressed as bright yellow proteins with elution profiles identical to that of wild-
type MMOR-FAD domain protein. Purified mutants had approximate molecular
weights of 27,000 kDa, as determined by SDS-PAGE gel electrophoresis. A scan
of an SDS-PAGE gel containing the purified mutants is shown in Figure 2-3.
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Absorbance spectra of wild-type protein and F245 mutant series are shown in
Figure 2-4. There is a slight blue shift in the flavin peak at 396 nm compared to
the wild type protein and mutants. The F245Y mutant has a maximum at 389 nm,
whereas F245L is shifted to 387 nm and F245A has a maximum at 386 nm. The
maxima at 270 nm and 458 nm found in the wild-type spectrum are unchanged
in these mutants.
Characterization of MMOR mutants. The full-length MMOR mutants were
expressed as dark brown proteins with elution profiles similar to that of wild-
type MMOR-FAD. Both F342A and F342L mutants eluted prior to solubilized Fe-
S clusters rather than after this band, as observed for wild-type protein. Purified
F342Y and F342A MMOR had approximate molecular weights of 37,500 kDa,
similar to that of wild-type MMOR, as shown in Figure 2-3. The F342L mutant
precipitated at higher concentrations and resulted in a large smear in the SDS-
PAGE gel. The iron content for all mutants was measured as 2.0 iron per protein,
in good agreement with the value of 2.0 Fe/protein reported for full-length
recombinant MMOR previously (23).
UV-visible absorbance spectra of the full-length mutants are shown in Figure
2-5. There is a shift in the maximum of the minor flavin peak from 396 nm in
MMOR to 389 nm in F342Y, with more pronounced shifts for F342L and F342A at
384 nm and 382 nm, respectively. Additionally, the [2Fe-2S] peak observed in the
oxidized MMOR at 338 nm is diminished in magnitude relative to the other
visible peaks in F342Y. In the F342A and F342L absorbance spectra, this peak is
no longer present.
Kinetic behavior of mutant reduction by NADH. Rate constants for the reduction
of MMOR-FAD and MMOR mutants by NADH are summarized in Table 2-1.
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Rate constants k2 and k3 (and k4) were determined by fitting data traces at 725 or
740 nm, whereas rate constant kl was determined from analysis of fits at 625 nm
with previously measured values of k2, k3 and k4.
In MMOR-FAD, only three rate constants for electron transfer from NADH to
FAD are observed, corresponding to the steps labeled in Scheme 2-la (22). The
first rate constant, k, corresponds NADH binding to a position for electron
transfer to take place, forming charge transfer complex 1 (CT1). The second rate
constant follows formation of charge transfer complex 2 (CT2), where electron
transfer to the oxidized flavin takes place, forming the two electron reduced form
of FAD, FADhq. The third rate constant measures decomposition of CT2,
monitored at 725 nm, by dissociation of oxidized NAD* from MMOR-FAD.
Figure 2-6 shows typical traces for wild-type MMOR-FAD and the three mutants
at 458, 625 and 725 nm. Disappearance of the absorbance peak for oxidized flavin
is followed at 458 nm, while FAD semiquinone formation and disappearance can
be traced at 625 nm (24). Values for k1 are half that of the wild-type rate constants
for mutants F245Y and F245A, whereas this rate constant is unchanged for
F245L. For mutant F245L there is virtually no decrease in k2 compared to wild-
type MMOR-FAD; this rate constant is slightly slower for F245Y, 132 s-1, and
about 50% of the native value for F245A. The difference in k3 values is most
striking for mutant F245A, being 6.1 s-1, corresponding to a fifteen-fold decrease
from wild-type activity. Rate constants measured for this third step are nearly
identical for F245Y and F245L, 61 s-1 and 66 s-l, respectively.
For full-length MMOR, a fourth kinetic step is required to fit data obtained at
625 nm, suggesting an additional step or pathway for electron transfer for
decomposition of FAD semiquinone. In MMOR, this step has been measured to
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have a rate constant of 25 s' l. Values determined for the first rate constant in full-
length mutants are roughly the same as k, for the MMOR-FAD mutants. The
F342Y mutant has values for rate constants that are slightly lower than those of
wild-type MMOR, and similar to rate constants measured for corresponding
FAD domain mutant, F245Y. The full-length alanine mutant, F342A, displays
values matching those measured for the FAD domain protein, with a k4 rate
constant three orders of magnitude slower than that of wild-type MMOR. The
F342L mutant displays radically different behavior from wild-type MMOR in its
semiquinone trace at 625 nm. Formation of semiquinone is followed by
immediate decay, rather than by the slow decay seen in traces of MMOR and the
other mutants in Figure 2-7. Rate constants for the F342L mutant from data
fitting are not significantly different from that of wild-type MMOR, however.
Discussion
Comparison of mutants to wild-type proteins. Conservative mutations of the C-
terminal phenylalanine in MMOR and its flavin binding domain result in
proteins with no loss in cofactor content or major conformational changes. All
mutants bind NADH and transfer electrons, thus allowing a comparison of their
activities to that of the wild-type proteins. The slight spectral shift towards
shorter wavelengths observed in the peak at 396 nm is observed in similar
mutants of FNR from Anabaena (20). This shift, due to FAD bound in the protein,
suggests that the binding environment around this cofactor becomes more
hydrophobic with changes to smaller residues like alanine and leucine, or, it may
be due to a change in interaction of the aromatic side chain with the flavin ring.
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A small shift is also observed for the F245Y and F342Y mutants, but the effect is
not as large as it is for alanine and leucine, not an unexpected result since the
mutation of phenylalanine to tyrosine is very conservative.
There is a definite change in the kinetic behavior of both the F245 and F342
mutants, which have diminished rates compared to wild type MMOR and
MMOR-FAD. The lowered rate constants observed for MMOR-FAD in mutants
F245Y and F245L remain within the same order of magnitude as that of the wild-
type protein. Full-length mutant F342Y also shows a decrease electron transfer
rates, but this process still occurs on a similar time scale to that of the wild-type
MMOR. The most dramatic slowing of electron transfer is observed in the F245A
and F342A mutants, where the rate-limiting electron transfer step of 90 s-
observed in both MMOR and MMOR-FAD is slowed to 6.2 s-l, a fifteen-fold
decrease in the rate constant. The rate of decay of CT2 observed at 725 nm in
MMOR-FAD and at 740 nm in MMOR corresponds to dissociation of NAD' from
the protein, along with simultaneous electron transfer from reduced FAD to the
[2Fe-2S] cluster in MMOR to form the FAD semiquinone. The decrease in k3 for
the alanine mutants lends support to the postulated role of Phe342 as a
conformational gate necessary to extrude oxidized NAD' rapidly to promote
electron transfer to the ferredoxin domain of the reductase.
The kinetic behavior of F342L is intriguing. Although no significant difference
in rate was observed for electron transfer in the FAD domain protein from wild-
type, the full-length mutant shows some surprising behavior in the decay of
semiquinone. Wild-type MMOR and both F342Y and F342A showed buildup of
FADsq in the trace at 625 nm, followed by a slow decay occurring beyond the
time scale measured in the experiment, indicating formation of FADsq resulting
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from transfer of electrons to the [2Fe-2S] cluster. In F342L, however, a rapid
decay of this complex is observed, suggesting alternate routes for this process
that prevent electron transfer to the ferredoxin domain from occurring. There
may be little driving force for electron transfer in this mutant, although the
measured rates were similar to those of both wild-type MMOR and MMOR-
FAD. Rapid back-electron transfer to the oxidized NAD' cofactor while still
bound to MMOR may be another possible explanation. Redox potential
measurements for the mutants are necessary to elucidate what occurs in this
mutant.
Role of F342 as a conformational gate for electron transfer. The difference in
electron transfer rates between the mutant FAD domain and wild-type proteins
confirms that Phe 342 does indeed play a role in modulating electron transfer
between NADH and the oxidized FAD. Surprisingly, the major effect is not in
the first rate constant, which reflects movement the nicotinamide ring of NADH
near the flavin ring, forming charge complex CT1 capable of electron transfer.
This step was initially expected to be perturbed to the greatest degree by
mutations of Phe 342, since it was anticipated that phenylalanine was physically
blocking the nicotinamide binding site prior to NADH binding. Rather, the effect
of this phenylalanine substitution is manifest in a large change for rate constant
k3, particularly for the alanine mutants. Loss of the large hydrophobic group
retards dissociation of NAD' from the reduced flavin, thereby slowing electron
transfer from the reduced flavin to the [2Fe-2S] cluster.
X-ray structures of oxidized FNR proteins reveal that the corresponding C-
terminal tyrosine side chain blocking access of the NADP* nicotinamide ring to
the flavin ring (25,26). Electron transfer in this system proceeds in the opposite
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direction, thus, the fully reduced flavin must be formed prior to interaction with
NADP* for electron transfer. Our mutant results suggest that phenylalanine is in
a conformation that allows the nicotinamide ring to access the flavin ring for
electron transfer, and that rate k does not involve a conformational change
requiring Phe342 to move out of the way. After reduction of the flavin has taken
place, a conformational change in the protein moves the phenylalanine side
chain into the nicotinamide binding site of NADH, pushing oxidized NAD' out
of the way to prevent back electron transfer and allowing electrons to be
transferred to reduce the ferredoxin cluster and ultimately the diiron site in
MMOH.
Conclusions. Based on studies of this series of Phe 245 and 342 mutants,
electron transfer from NADH to oxidized FAD is regulated by the action of Phe
342. Removal of large hydrophobic groups slows the rate of NAD' dissociation
dramatically, as observed by the significant drop in rate constant k3 for F245A
and F342A. The rapid loss of semiquinone after reduction in the F342L mutant
suggests that electron transfer to the ferredoxin domain can not occur because of
another pathway for electron transfer, potentially implicating requirement of an
aromatic interaction with the flavin ring to stabilize the semiquinone form of
FAD to allow electron transfer. Redox potentials for cofactors in these mutants
need to be measured to explain further these results and to verify that the change
in ET rates is due to conformational restrictions rather than alterations in the
driving force for electron transfer.
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Table 2-1: Kinetic parameters for MMOR-FAD and MMOR mutants
kl (s-) ' k2 ( ) k s k3 k4 (s ..
MMOR-FAD
Wild-typea 240 (20) 188 (7) 89 (4)
F245Y 150 (20) 132 (3) 61 (2)
F245A 110 (20) 92 (2) 6.1(2)
F245L 230 (40) 180 (10) 66 (8)
MMOR
Wild-typeb 350 193 90 29 (1)
F342Y 140 (20) 108 (3) 72 (2) 13 (1)
F342A 120 (10) 93 (2) 6.4 (1) 0.014 (4)
F342L 220 (30) 123 (2) 82 (3) 17 (2)
a As reported in ref. (22)
b Rate constants reported in ref. (23)
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Scheme 2-1. NADH binding and electron transfer steps for (A) MMOR-FAD (22)
and (B) full-length MMOR (23).
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FIGURE 2-1. Domain arrangements of proteins in the ferredoxin-NADP+ reductase
subfamily. MMOR and BenC have a [2Fe-2S] ferredoxin domain linked at the N-
terminus, while PDR has its ferredoxin domain linked as a C-terminal domain.
Ferredoxin and FNR are expressed as separate proteins in photosynthetic
organisms.
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Figure 2-2. FAD Binding site of MMOR-FAD. Nearby residues with significant
interactions are shown. Residue Phe 245, or Phe 342 in the full-length protein, is
shown in orange, and is proposed to act as a conformational gate. In this
structure of the reduced protein, the aromatic ring of Phe 245 is next to the flavin
ring, blocking the nicotinamide binding site. This figure is taken from reference
(16).
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FIGURE 2-3. SDS-PAGE gel of purified MMOR and MMOR-FAD mutants.
Proteins run as monomers on the gel, with molecular weights of 27 kDa for
MMOR-FAD proteins and 37.5 kDa for MMOR proteins. The center lane contains
molecular weight markers.
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FIGURE 2-4. Spectra of MMOR-FAD wild-type protein and F245 mutants,
characteristic of bound FAD. No significant shift is observed for the maximum at
458 nm, but there is a change in shifts of mutants for the peak at 396 nm in the
wild-type protein.
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FIGURE 2-5. UV-Visible spectra of full-length MMOR wild-type protein and F342
mutants. There is a shift for the peak at 396 nm as observed for the F245 mutants.
Additionally, the peak at 338 nm corresponding to the [2Fe-2S] cluster appears as
a shoulder for F342Y and F342A, and is nonexistent for F342L.
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FIGURE 2-6. Single-wavelength stopped flow traces of (A)wild-type MMOR-FAD,
(B) F245Y, (C) F245A and (D) F245L. Traces were followed at wavelengths of 458
nm, 625 nm and 725 nm as indicated above. All traces are shown on a
logarithmic time scale.
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FIGURE 2-7. Single-wavelength stopped flow traces of (A)wild-type MMOR, (B)
F342Y, (C) F342A and (D) F342L. Traces were followed at wavelengths of 458 nm,
625 nm and 740 nm as indicated above. All traces are shown on a logarithmic
time scale.
83
A B
06
04
'3:
0.2
0.12
0.1
0.5
0.
0.04
625 nm
L . 450 nm
740 nrn
11
o 4;w
109
08
10
D
r4
S4
07
018
0.56
0.14
0.S
time (s)
i
:
.
84
85
BIOGRAPHICAL NOTE
The author was born on June 26, 1979 in Lima, Ohio, the daughter of Phillip and
Sharon Chatwood. After graduating as valedictorian from Greenville High
School in 1997, she attended Miami University in Oxford, Ohio as a Benjamin
Harrison scholar. She earned several chemistry awards, including outstanding
chemistry student, as well as being named a Goldwater scholar prior to
graduating summa cum laude with a B.S. in biochemistry in 2001. A recipient of
a National Science Foundation graduate fellowship, she attended the
Massachusetts Institute of Technology to work in the laboratory of Professor
Stephen Lippard. She is pursuing a pharmacy degree from the State University
of New York at Buffalo.
86
Lisa L. Chatwood
Education
S.M., Biological Chemistry
GPA 4.80 /5.00
2001-2004
B.S., Biochemistry
Summa Cum Laude, GPA 3.90/4.00
1997-2001
Massachusetts Institute
of Technology
Cambridge, MA
Miami University
Oxford, OH
Awards
NSF Predoctoral Fellow
USA Today All-Academic Team Honorable Mention
Goldwater Scholar
Board of Trustees Harrison Scholar
Merck Award for Outstanding Senior Chemistry Student
Outstanding Inorganic Student
Outstanding Organic Student
Buckingham Scholarship (Chemistry)
Procter and Gamble Scholarship (Chemistry)
National Merit Scholar
Publications
Chatwood, L.L., Muiller, J., Gross, J.D., Wagner, G., Lippard, S.J. (2004) NMR
Structure of the Flavin Domain of Soluble Methane Monooxygenase from
Methylococcus capsulatus (Bath) Biochemistry, in press.
Brandt, J.J., Chatwood, L.L., Crowder, M.W. (2000) Analysis of three
overexpression systems for VanX, the zinc(II) dipeptidase required for high-level
vancomycin resistance in bacteria. Protein Expression and Purification 20 (2), 300-
307.
Yang KW, Brandt JJ, Chatwood LL, Crowder, M.W. (2000) Phosphonamidate and
phosphothioate dipeptides as potential inhibitors of VanX. Bioorganic and
Medicinal Chemistry Letters 10 (10), 1085-1087.
Brandt JJ, Chatwood LL, Yang KW, Crowder, M.W. (1999) Continuous assay for
VanX, the D-Alanyl-D-Alanine dipeptidase required for high-level vancomycin
resistance. Analytical Biochemistry 272 (1): 94-99.
87
Presentations
L.L. Chatwood, J. MUiller, J.D. Gross, G. Wagner, S.J. Lippard. NMR structure of
the FAD and NADH binding domains of the reductase component of soluble
methane monooxygenase from Methylococcus capsulatus (Bath). 226th National
ACS Meeting (New York, NY, September 2003).
L.L. Chatwood, J.J. Brandt, K.W. Yang, M.W. Crowder. VanX, a metalloenzyme
conferring high-level vancomycin resistance. Ohio Inorganic Chemistry
Graduate Student conference (Columbus, Ohio, November 2000).
